The Market Reports

Index

1 Gadobutrol (CAS 138071-82-6) Market Overview
1.1 Product Overview and Scope of Gadobutrol (CAS 138071-82-6)
1.2 Gadobutrol (CAS 138071-82-6) Segment by Type
1.2.1 Global Gadobutrol (CAS 138071-82-6) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL)
1.2.3 Pharmacy Bulk Packages (30 mL and 65 mL)
1.3 Gadobutrol (CAS 138071-82-6) Segment by Application
1.3.1 Global Gadobutrol (CAS 138071-82-6) Sales Comparison by Application: (2021-2027)
1.3.2 Adults
1.3.3 Children
1.4 Global Gadobutrol (CAS 138071-82-6) Market Size Estimates and Forecasts
1.4.1 Global Gadobutrol (CAS 138071-82-6) Revenue 2016-2027
1.4.2 Global Gadobutrol (CAS 138071-82-6) Sales 2016-2027
1.4.3 Gadobutrol (CAS 138071-82-6) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gadobutrol (CAS 138071-82-6) Market Competition by Manufacturers
2.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gadobutrol (CAS 138071-82-6) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Sites, Area Served, Product Type
2.5 Gadobutrol (CAS 138071-82-6) Market Competitive Situation and Trends
2.5.1 Gadobutrol (CAS 138071-82-6) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gadobutrol (CAS 138071-82-6) Players Market Share by Revenue
2.5.3 Global Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario by Region
3.1 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gadobutrol (CAS 138071-82-6) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
3.3.1 North America Gadobutrol (CAS 138071-82-6) Sales by Country
3.3.2 North America Gadobutrol (CAS 138071-82-6) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
3.4.1 Europe Gadobutrol (CAS 138071-82-6) Sales by Country
3.4.2 Europe Gadobutrol (CAS 138071-82-6) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Region
3.5.1 Asia Pacific Gadobutrol (CAS 138071-82-6) Sales by Region
3.5.2 Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
3.6.1 Latin America Gadobutrol (CAS 138071-82-6) Sales by Country
3.6.2 Latin America Gadobutrol (CAS 138071-82-6) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gadobutrol (CAS 138071-82-6) Market Facts & Figures by Country
3.7.1 Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales by Country
3.7.2 Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Gadobutrol (CAS 138071-82-6) Historic Market Analysis by Type
4.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
4.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Type (2016-2021)
4.3 Global Gadobutrol (CAS 138071-82-6) Price by Type (2016-2021)

5 Global Gadobutrol (CAS 138071-82-6) Historic Market Analysis by Application
5.1 Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
5.2 Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Application (2016-2021)
5.3 Global Gadobutrol (CAS 138071-82-6) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bayer HealthCare Pharmaceuticals
6.1.1 Bayer HealthCare Pharmaceuticals Corporation Information
6.1.2 Bayer HealthCare Pharmaceuticals Description and Business Overview
6.1.3 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product Portfolio
6.1.5 Bayer HealthCare Pharmaceuticals Recent Developments/Updates
6.2 SWAPNROOP DRUGS & PHARMACEUTICALS
6.2.1 SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
6.2.2 SWAPNROOP DRUGS & PHARMACEUTICALS Description and Business Overview
6.2.3 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product Portfolio
6.2.5 SWAPNROOP DRUGS & PHARMACEUTICALS Recent Developments/Updates
6.3 Manus Aktteva Biopharma
6.3.1 Manus Aktteva Biopharma Corporation Information
6.3.2 Manus Aktteva Biopharma Description and Business Overview
6.3.3 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product Portfolio
6.3.5 Manus Aktteva Biopharma Recent Developments/Updates
6.4 Jilin Tely Imp & Exp
6.4.1 Jilin Tely Imp & Exp Corporation Information
6.4.2 Jilin Tely Imp & Exp Description and Business Overview
6.4.3 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product Portfolio
6.4.5 Jilin Tely Imp & Exp Recent Developments/Updates
6.5 JinYan Chemicals (ShangHai)
6.5.1 JinYan Chemicals (ShangHai) Corporation Information
6.5.2 JinYan Chemicals (ShangHai) Description and Business Overview
6.5.3 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product Portfolio
6.5.5 JinYan Chemicals (ShangHai) Recent Developments/Updates
6.6 BOC Sciences
6.6.1 BOC Sciences Corporation Information
6.6.2 BOC Sciences Description and Business Overview
6.6.3 BOC Sciences Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 BOC Sciences Gadobutrol (CAS 138071-82-6) Product Portfolio
6.6.5 BOC Sciences Recent Developments/Updates
6.7 LGM Pharma
6.6.1 LGM Pharma Corporation Information
6.6.2 LGM Pharma Description and Business Overview
6.6.3 LGM Pharma Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 LGM Pharma Gadobutrol (CAS 138071-82-6) Product Portfolio
6.7.5 LGM Pharma Recent Developments/Updates
6.8 Advanced Technology & Industrail
6.8.1 Advanced Technology & Industrail Corporation Information
6.8.2 Advanced Technology & Industrail Description and Business Overview
6.8.3 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product Portfolio
6.8.5 Advanced Technology & Industrail Recent Developments/Updates
6.9 MedKoo Biosciences
6.9.1 MedKoo Biosciences Corporation Information
6.9.2 MedKoo Biosciences Description and Business Overview
6.9.3 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product Portfolio
6.9.5 MedKoo Biosciences Recent Developments/Updates

7 Gadobutrol (CAS 138071-82-6) Manufacturing Cost Analysis
7.1 Gadobutrol (CAS 138071-82-6) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
7.4 Gadobutrol (CAS 138071-82-6) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gadobutrol (CAS 138071-82-6) Distributors List
8.3 Gadobutrol (CAS 138071-82-6) Customers

9 Gadobutrol (CAS 138071-82-6) Market Dynamics
9.1 Gadobutrol (CAS 138071-82-6) Industry Trends
9.2 Gadobutrol (CAS 138071-82-6) Growth Drivers
9.3 Gadobutrol (CAS 138071-82-6) Market Challenges
9.4 Gadobutrol (CAS 138071-82-6) Market Restraints

10 Global Market Forecast
10.1 Gadobutrol (CAS 138071-82-6) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gadobutrol (CAS 138071-82-6) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gadobutrol (CAS 138071-82-6) by Type (2022-2027)
10.2 Gadobutrol (CAS 138071-82-6) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gadobutrol (CAS 138071-82-6) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gadobutrol (CAS 138071-82-6) by Application (2022-2027)
10.3 Gadobutrol (CAS 138071-82-6) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gadobutrol (CAS 138071-82-6) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gadobutrol (CAS 138071-82-6) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Gadobutrol (CAS 138071-82-6) Sales (M L) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Gadobutrol (CAS 138071-82-6) Sales (M L) Comparison by Application (2021-2027)
Table 3. Global Gadobutrol (CAS 138071-82-6) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gadobutrol (CAS 138071-82-6) Covered in This Study
Table 5. Global Gadobutrol (CAS 138071-82-6) Sales (M L) of Key Manufacturers (2016-2021)
Table 6. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Gadobutrol (CAS 138071-82-6) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gadobutrol (CAS 138071-82-6) Average Price (USD/L) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gadobutrol (CAS 138071-82-6) Manufacturing Sites and Area Served
Table 11. Manufacturers Gadobutrol (CAS 138071-82-6) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gadobutrol (CAS 138071-82-6) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gadobutrol (CAS 138071-82-6) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gadobutrol (CAS 138071-82-6) Sales by Region (2016-2021) & (M L)
Table 16. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2021)
Table 17. Global Gadobutrol (CAS 138071-82-6) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021) & (M L)
Table 19. North America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2021)
Table 20. North America Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2021)
Table 22. Europe Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021) & (M L)
Table 23. Europe Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2021)
Table 24. Europe Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gadobutrol (CAS 138071-82-6) Sales by Region (2016-2021) & (M L)
Table 27. Asia Pacific Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021) & (M L)
Table 31. Latin America Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2021)
Table 32. Latin America Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales by Country (2016-2021) & (M L)
Table 35. Middle East and Africa Gadobutrol (CAS 138071-82-6) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gadobutrol (CAS 138071-82-6) Revenue Market Share by Country (2016-2021)
Table 38. Global Gadobutrol (CAS 138071-82-6) Sales (M L) by Type (2016-2021)
Table 39. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Type (2016-2021)
Table 40. Global Gadobutrol (CAS 138071-82-6) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Type (2016-2021)
Table 42. Global Gadobutrol (CAS 138071-82-6) Price (USD/L) by Type (2016-2021)
Table 43. Global Gadobutrol (CAS 138071-82-6) Sales (M L) by Application (2016-2021)
Table 44. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Application (2016-2021)
Table 45. Global Gadobutrol (CAS 138071-82-6) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Application (2016-2021)
Table 47. Global Gadobutrol (CAS 138071-82-6) Price (USD/L) by Application (2016-2021)
Table 48. Bayer HealthCare Pharmaceuticals Corporation Information
Table 49. Bayer HealthCare Pharmaceuticals Description and Business Overview
Table 50. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 51. Bayer HealthCare Pharmaceuticals Gadobutrol (CAS 138071-82-6) Product
Table 52. Bayer HealthCare Pharmaceuticals Recent Developments/Updates
Table 53. SWAPNROOP DRUGS & PHARMACEUTICALS Corporation Information
Table 54. SWAPNROOP DRUGS & PHARMACEUTICALS Description and Business Overview
Table 55. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 56. SWAPNROOP DRUGS & PHARMACEUTICALS Gadobutrol (CAS 138071-82-6) Product
Table 57. SWAPNROOP DRUGS & PHARMACEUTICALS Recent Developments/Updates
Table 58. Manus Aktteva Biopharma Corporation Information
Table 59. Manus Aktteva Biopharma Description and Business Overview
Table 60. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 61. Manus Aktteva Biopharma Gadobutrol (CAS 138071-82-6) Product
Table 62. Manus Aktteva Biopharma Recent Developments/Updates
Table 63. Jilin Tely Imp & Exp Corporation Information
Table 64. Jilin Tely Imp & Exp Description and Business Overview
Table 65. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 66. Jilin Tely Imp & Exp Gadobutrol (CAS 138071-82-6) Product
Table 67. Jilin Tely Imp & Exp Recent Developments/Updates
Table 68. JinYan Chemicals (ShangHai) Corporation Information
Table 69. JinYan Chemicals (ShangHai) Description and Business Overview
Table 70. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 71. JinYan Chemicals (ShangHai) Gadobutrol (CAS 138071-82-6) Product
Table 72. JinYan Chemicals (ShangHai) Recent Developments/Updates
Table 73. BOC Sciences Corporation Information
Table 74. BOC Sciences Description and Business Overview
Table 75. BOC Sciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 76. BOC Sciences Gadobutrol (CAS 138071-82-6) Product
Table 77. BOC Sciences Recent Developments/Updates
Table 78. LGM Pharma Corporation Information
Table 79. LGM Pharma Description and Business Overview
Table 80. LGM Pharma Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 81. LGM Pharma Gadobutrol (CAS 138071-82-6) Product
Table 82. LGM Pharma Recent Developments/Updates
Table 83. Advanced Technology & Industrail Corporation Information
Table 84. Advanced Technology & Industrail Description and Business Overview
Table 85. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 86. Advanced Technology & Industrail Gadobutrol (CAS 138071-82-6) Product
Table 87. Advanced Technology & Industrail Recent Developments/Updates
Table 88. MedKoo Biosciences Corporation Information
Table 89. MedKoo Biosciences Description and Business Overview
Table 90. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Sales (M L), Revenue (Million US$), Price (USD/L) and Gross Margin (2016-2021)
Table 91. MedKoo Biosciences Gadobutrol (CAS 138071-82-6) Product
Table 92. MedKoo Biosciences Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Gadobutrol (CAS 138071-82-6) Distributors List
Table 96. Gadobutrol (CAS 138071-82-6) Customers List
Table 97. Gadobutrol (CAS 138071-82-6) Market Trends
Table 98. Gadobutrol (CAS 138071-82-6) Growth Drivers
Table 99. Gadobutrol (CAS 138071-82-6) Market Challenges
Table 100. Gadobutrol (CAS 138071-82-6) Market Restraints
Table 101. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Type (2022-2027) & (M L)
Table 102. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Type (2022-2027)
Table 103. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 104. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Type (2022-2027)
Table 105. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Application (2022-2027) & (M L)
Table 106. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Application (2022-2027)
Table 107. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 108. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Application (2022-2027)
Table 109. Global Gadobutrol (CAS 138071-82-6) Sales Forecast by Region (2022-2027) & (M L)
Table 110. Global Gadobutrol (CAS 138071-82-6) Sales Market Share Forecast by Region (2022-2027)
Table 111. Global Gadobutrol (CAS 138071-82-6) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 112. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share Forecast by Region (2022-2027)
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gadobutrol (CAS 138071-82-6)
Figure 2. Global Gadobutrol (CAS 138071-82-6) Market Share by Type in 2020 & 2027
Figure 3. Single Dose Vials (2 mL, 7.5 mL, 10mL, and 15 mL) Product Picture
Figure 4. Pharmacy Bulk Packages (30 mL and 65 mL) Product Picture
Figure 5. Global Gadobutrol (CAS 138071-82-6) Market Share by Application in 2020 & 2027
Figure 6. Adults
Figure 7. Children
Figure 8. Global Gadobutrol (CAS 138071-82-6) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Gadobutrol (CAS 138071-82-6) Market Size 2016-2027 (US$ Million)
Figure 10. Global Gadobutrol (CAS 138071-82-6) Sales 2016-2027 (M L)
Figure 11. Global Gadobutrol (CAS 138071-82-6) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Gadobutrol (CAS 138071-82-6) Sales Share by Manufacturers in 2020
Figure 13. Global Gadobutrol (CAS 138071-82-6) Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Gadobutrol (CAS 138071-82-6) Players: Market Share by Revenue in 2020
Figure 15. Gadobutrol (CAS 138071-82-6) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region (2016-2021)
Figure 17. Global Gadobutrol (CAS 138071-82-6) Sales Market Share by Region in 2020
Figure 18. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region (2016-2021)
Figure 19. Global Gadobutrol (CAS 138071-82-6) Revenue Market Share by Region in 2020
Figure 20. U.S. Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Gadobutrol (CAS 138071-82-6) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Gadobutrol (CAS 138071-82-6) by Type (2016-2021)
Figure 45. Sales Market Share of Gadobutrol (CAS 138071-82-6) by Application (2016-2021)
Figure 46. Sales Market Share of Gadobutrol (CAS 138071-82-6) by Application in 2020
Figure 47. Revenue Share of Gadobutrol (CAS 138071-82-6) by Application (2016-2021)
Figure 48. Revenue Share of Gadobutrol (CAS 138071-82-6) by Application in 2020
Figure 49. Manufacturing Cost Structure of Gadobutrol (CAS 138071-82-6)
Figure 50. Manufacturing Process Analysis of Gadobutrol (CAS 138071-82-6)
Figure 51. Gadobutrol (CAS 138071-82-6) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed